Abeona Therapeutics Inc ABEO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:51 PM EDT
1.28UNCH (UNCH)
Volume
12,086
Close
1.28quote price arrow up+0.03 (+2.40%)
Volume
1,555,722
52 week range
0.99 - 3.79

...

Loading . . .
  • Open1.28
  • Day High1.34
  • Day Low1.23
  • Prev Close1.25
  • 52 Week High3.79
  • 52 Week High Date02/09/21
  • 52 Week Low0.99
  • 52 Week Low Date11/03/20

Key Stats

  • Market Cap126.75M
  • Shares Out99.02M
  • 10 Day Average Volume1.84M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change-18.47

KEY STATS

  • Open1.28
  • Day High1.34
  • Day Low1.23
  • Prev Close1.25
  • 52 Week High3.79
  • 52 Week High Date02/09/21
  • 52 Week Low0.99
  • 52 Week Low Date11/03/20
  • Market Cap126.75M
  • Shares Out99.02M
  • 10 Day Average Volume1.84M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change-18.47

RATIOS/PROFITABILITY

  • EPS (TTM)-0.56
  • P/E (TTM)-2.28
  • Fwd P/E (NTM)-2.05
  • EBITDA (MRQ)-44.468M
  • ROE (MRQ)-45.93%
  • Revenue (MRQ)10.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-520.77%
  • Debt To Equity (MRQ)1.86%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Abeona Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). It is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB)...
Steven Rouhandeh
Chairman
Michael Amoroso
President
Edward Carr
Chief Accounting Officer
Address
1330 Avenue of the Americas Fl 33
New York, NY
10019-5442
United States

Top Peers

SYMBOLLASTCHG%CHG
XCUR
Exicure Inc
1.39+0.03+2.21%
ISR
IsoRay Inc
0.7061+0.0115+1.66%
CNCE
Concert Pharmaceuticals Inc
3.46+0.18+5.49%
YMTX
Yumanity Therapeutics Inc
9.13+0.49+5.67%
CBIO
Catalyst Biosciences Inc
4.31+0.17+4.11%